Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Marshalls revenues fall amid subdued demand

(Sharecast News) - Marshalls said on Thursday that adjusted pre-tax profit for the full year is set to be in line with its expectations as it reported a drop in revenue amid subdued demand. In an update for the year to the end of December 2023, the landscape products manufacturer said group revenue fell 7% on the year to £671m. On a like-for-like basis, revenue was down 13%. Marshalls pointed to weaker demand from house builders and continued subdued activity in the repair, maintenance and improvement market.

Revenue from the landscape products segment declined 18% to £321m. On a like-for-like basis, after adjusting for the disposal of Marshalls NV in April 2023, revenues were down 16%.

Meanwihle, the building products arm saw revenues fall 12% to £170m and Marley roofing products revenue was £180m, down 9% on a LFL basis.

During the year, Marshalls took actions "to improve agility and right-size the business through reducing capacity and costs". These included the closure or mothballing of factories, a reduction in shifts and capacity in other facilities, and a reorganisation of commercial and support functions.

These are expected to deliver net annualised savings of around £11m, which is £2m higher than previous estimates.

"Execution of the group's strategy is underpinned by our strong market positions, established brands and focused investment plans to drive ongoing operational improvement," Marshalls said. "Notwithstanding the anticipated short-term challenges, the board remains confident that the long-term market growth drivers and a focus on executing key strategic initiatives, will underpin a material improvement in profitability when markets recover."

Share this article

Related Sharecast Articles

Oxford Biomedica confident as it moves away from vaccine era
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.
N Brown chairman Ron McMillan to retire
(Sharecast News) - N Brown said on Monday that chairman Ron McMillan will be retiring and stepping down from the board with effect from 30 April for personal reasons.
McCarthy out, Adshead in as Ultimate Products chair
(Sharecast News) - Ultimate Products, the parent of homeware brands including Salter and Beldray, announced a change in its leadership on Monday, with James 'Jim' McCarthy deciding to step down as non-executive chair from 31 July.
Supermarket Income REIT buys portfolio of Carrefour supermarkets for €75.3m
(Sharecast News) - Supermarket Income REIT said on Monday that it has bought a portfolio of Carrefour supermarkets in France through a sale and leaseback transaction for €75.3m.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.